{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T19:39:40Z","timestamp":1740166780309,"version":"3.37.3"},"reference-count":19,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T00:00:00Z","timestamp":1623196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,8,17]]},"DOI":"10.1093\/jpids\/piab039","type":"journal-article","created":{"date-parts":[[2021,5,6]],"date-time":"2021-05-06T19:36:51Z","timestamp":1620329811000},"page":"755-756","source":"Crossref","is-referenced-by-count":1,"title":["Echinocandins in Pediatric Invasive Candidiasis and the Challenges of Antifungal Use in Children"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6284-612X","authenticated-orcid":false,"given":"Daniel K","family":"Yeoh","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital, Perth, Western Australia, Australia"},{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia"},{"name":"National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2017-0683","authenticated-orcid":false,"given":"Christopher C","family":"Blyth","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Perth Children\u2019s Hospital, Perth, Western Australia, Australia"},{"name":"Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute and School of Medicine, University of Western Australia, Perth, Western Australia, Australia"},{"name":"Department of Microbiology, Pathwest Laboratory Medicine, QEII Medical Centre, Perth, Western Australia, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brendan J","family":"McMullan","sequence":"additional","affiliation":[{"name":"Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville, Victoria, Australia"},{"name":"National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia"},{"name":"Department of Immunology and Infectious Diseases, Sydney Children\u2019s Hospital, Randwick, New South Wales, Australia"},{"name":"School of Women\u2019s and Children\u2019s Health, UNSW, Sydney, New South Wales, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2021,6,9]]},"reference":[{"issue":"5","key":"2021081716512174400_CIT0001","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1542\/peds.2008-2055","article-title":"Not just little adults: candidemia epidemiology, molecular characterization, and antifungal susceptibility in neonatal and pediatric patients","volume":"123","author":"Blyth","year":"2009","journal-title":"Pediatrics"},{"issue":"8","key":"2021081716512174400_CIT0002","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s40265-014-0227-3","article-title":"Pharmacokinetics and pharmacodynamics of antifungals in children: clinical implications","volume":"74","author":"Autmizguine","year":"2014","journal-title":"Drugs"},{"issue":"8","key":"2021081716512174400_CIT0003","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1093\/cid\/cis021","article-title":"Impact of treatment strategy on outcomes in patients with candidemia and other forms of invasive candidiasis: a patient-level quantitative review of randomized trials","volume":"54","author":"Andes","year":"2012","journal-title":"Clin Infect Dis"},{"journal-title":"J Pediatric Infect Dis Soc","article-title":"Comparative effectiveness of triazoles or amphotericin B formulations","year":"2021","key":"2021081716512174400_CIT0004"},{"issue":"3","key":"2021081716512174400_CIT0005","doi-asserted-by":"crossref","first-page":"433","DOI":"10.3324\/haematol.2016.152900","article-title":"ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients","volume":"102","author":"Tissot","year":"2017","journal-title":"Haematologica"},{"issue":"4","key":"2021081716512174400_CIT0006","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/ciw326","article-title":"Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the Infectious Diseases Society of America","volume":"63","author":"Patterson","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"2021081716512174400_CIT0007","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1093\/jac\/dkw056","article-title":"Voriconazole dosing and therapeutic drug monitoring in children: experience from a paediatric tertiary care centre","volume":"71","author":"Boast","year":"2016","journal-title":"J Antimicrob Chemother"},{"issue":"10020","key":"2021081716512174400_CIT0008","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/S0140-6736(15)01159-9","article-title":"Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial","volume":"387","author":"Maertens","year":"2016","journal-title":"Lancet"},{"issue":"10273","key":"2021081716512174400_CIT0009","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S0140-6736(21)00219-1","article-title":"Posaconazole versus voriconazole for primary treatment of invasive aspergillosis: a phase 3, randomised, controlled, non-inferiority trial","volume":"397","author":"Maertens","year":"2021","journal-title":"Lancet"},{"issue":"3","key":"2021081716512174400_CIT0010","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1093\/jac\/dkz481","article-title":"Evaluation of target attainment of oral posaconazole suspension in immunocompromised children","volume":"75","author":"Lai","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"3","key":"2021081716512174400_CIT0011","doi-asserted-by":"crossref","first-page":"e01783","DOI":"10.1128\/AAC.01783-19","article-title":"A case series and literature review of isavuconazole use in pediatric patients with hemato-oncologic diseases and hematopoietic stem cell transplantation","volume":"64","author":"Decembrino","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"2021081716512174400_CIT0012","doi-asserted-by":"crossref","first-page":"106084","DOI":"10.1016\/j.ijantimicag.2020.106084","article-title":"Pharmacokinetics and safety of posaconazole intravenous solution and powder for oral suspension in children with neutropenia: an open-label, sequential dose-escalation trial","volume":"56","author":"Groll","year":"2020","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"2021081716512174400_CIT0013","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1093\/jac\/dkz359","article-title":"Plasma exposures following posaconazole delayed-release tablets in immunocompromised children and adolescents","volume":"74","author":"Tragiannidis","year":"2019","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"2021081716512174400_CIT0014","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/jac\/dkaa382","article-title":"Clinical experience with SUBA-itraconazole at a tertiary paediatric hospital","volume":"76","author":"Abbotsford","year":"2020","journal-title":"J Antimicrob Chemother."},{"issue":"17","key":"2021081716512174400_CIT0015","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1001\/jama.2019.15702","article-title":"Effect of caspofungin vs fluconazole prophylaxis on invasive fungal disease among children and young adults with acute myeloid leukemia: a randomized clinical trial","volume":"322","author":"Fisher","year":"2019","journal-title":"JAMA"},{"issue":"1","key":"2021081716512174400_CIT0016","article-title":"Invasive candidiasis in infants and children: recent advances in epidemiology, diagnosis, and treatment","volume":"5","author":"Walsh","year":"2019","journal-title":"J Fungi (Basel)"},{"issue":"2","key":"2021081716512174400_CIT0017","doi-asserted-by":"crossref","first-page":"ofaa016","DOI":"10.1093\/ofid\/ofaa016","article-title":"Hope on the horizon: novel fungal treatments in development","volume":"7","author":"Rauseo","year":"2020","journal-title":"Open Forum Infect Dis"},{"issue":"3","key":"2021081716512174400_CIT0018","doi-asserted-by":"crossref","first-page":"e20171849","DOI":"10.1542\/peds.2017-1849","article-title":"Pediatric antibacterial and antifungal trials from 2007 to 2017","volume":"142","author":"Thaden","year":"2018","journal-title":"Pediatrics"},{"issue":"10","key":"2021081716512174400_CIT0019","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/INF.0000000000001996","article-title":"A phase 3 study of micafungin versus amphotericin b deoxycholate in infants with invasive candidiasis","volume":"37","author":"Benjamin","year":"2018","journal-title":"Pediatr Infect Dis J"}],"container-title":["Journal of the Pediatric Infectious Diseases Society"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/10\/7\/755\/39768685\/piab039.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jpids\/article-pdf\/10\/7\/755\/39768685\/piab039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T16:52:01Z","timestamp":1629219121000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jpids\/article\/10\/7\/755\/6295432"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,9]]},"references-count":19,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,6,9]]},"published-print":{"date-parts":[[2021,8,17]]}},"URL":"https:\/\/doi.org\/10.1093\/jpids\/piab039","relation":{},"ISSN":["2048-7207"],"issn-type":[{"type":"electronic","value":"2048-7207"}],"subject":[],"published-other":{"date-parts":[[2021,7,1]]},"published":{"date-parts":[[2021,6,9]]}}}